Qunxiong Pan

455 total citations
16 papers, 361 citations indexed

About

Qunxiong Pan is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Qunxiong Pan has authored 16 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 9 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Qunxiong Pan's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (3 papers). Qunxiong Pan is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (3 papers). Qunxiong Pan collaborates with scholars based in China. Qunxiong Pan's co-authors include Chongren Wang, Jianhua Zhang, Xuejin Wang, Xiaoyu Liu, Mingzhu Li, Jiangman Zhao, Shouxin Wu, Mingzhu Li, Yaping Xu and Ya‐Yun Chen and has published in prestigious journals such as PLoS ONE, Carcinogenesis and Oncotarget.

In The Last Decade

Qunxiong Pan

16 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qunxiong Pan China	9	212	193	114	82	62	16	361
Canrong Lu China	13	207 1.0×	138 0.7×	114 1.0×	86 1.0×	50 0.8×	22	368
Xiaping Wang China	9	164 0.8×	183 0.9×	102 0.9×	59 0.7×	46 0.7×	20	330
Shuli Tang China	9	162 0.8×	171 0.9×	81 0.7×	46 0.6×	34 0.5×	18	281
Grażyna Drabik Poland	14	134 0.6×	117 0.6×	134 1.2×	100 1.2×	62 1.0×	28	361
De-Bing Shi China	9	275 1.3×	264 1.4×	91 0.8×	58 0.7×	46 0.7×	9	473
Jianjie Zhao China	11	194 0.9×	163 0.8×	50 0.4×	34 0.4×	68 1.1×	16	345
Kiyoyuki Kobayashi Japan	10	162 0.8×	87 0.5×	91 0.8×	48 0.6×	75 1.2×	19	293
Seiji Onogawa Japan	10	241 1.1×	153 0.8×	254 2.2×	96 1.2×	127 2.0×	23	475
Yunhong Tian China	10	123 0.6×	77 0.4×	106 0.9×	76 0.9×	77 1.2×	29	307
Gui-Ming Zhang China	12	132 0.6×	118 0.6×	144 1.3×	157 1.9×	77 1.2×	21	361

Countries citing papers authored by Qunxiong Pan

Since Specialization

Citations

This map shows the geographic impact of Qunxiong Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qunxiong Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qunxiong Pan more than expected).

Fields of papers citing papers by Qunxiong Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qunxiong Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qunxiong Pan. The network helps show where Qunxiong Pan may publish in the future.

Co-authorship network of co-authors of Qunxiong Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Qunxiong Pan. A scholar is included among the top collaborators of Qunxiong Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qunxiong Pan. Qunxiong Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Pan, Qunxiong, et al.. (2024). NOP2/Sun RNA Methyltransferase 4 Regulates the Mammalian Target of Rapamycin Signaling Pathway to Promote Hepatocellular Carcinoma Progression. The Turkish Journal of Gastroenterology. 36(1). 24–33. 2 indexed citations

Pan, Qunxiong, et al.. (2023). Intermediate endpoints as surrogates for outcomes in cancer immunotherapy: a systematic review and meta-analysis of phase 3 trials. EClinicalMedicine. 63. 102156–102156. 7 indexed citations

Pan, Qunxiong, et al.. (2023). NKD2 Trigger NF-κB Signaling Pathway and Facilitates Thyroid Cancer Cell Proliferation. Molecular Biotechnology. 65(11). 1846–1856. 4 indexed citations

Liu, Xiaoyu, et al.. (2022). Circ_0001658 regulates PI3K/AKT signaling via the miR-671-5p/ITGA2 axis and affects the progress of papillary thyroid carcinoma. Annals of Translational Medicine. 10(18). 1001–1001. 7 indexed citations

Zhang, Jianhua, et al.. (2020). Prediction of Poor Prognosis of HCC by Early Warning Model for Co-Expression of miRNA and mRNA Based on Bioinformatics Analysis. Technology in Cancer Research & Treatment. 19. 1079227001–1079227001. 2 indexed citations

Li, Mingzhu, et al.. (2019). Downregulation of LncRNA GAS5 promotes liver cancer proliferation and drug resistance by decreasing PTEN expression. Molecular Genetics and Genomics. 295(1). 251–260. 58 indexed citations

Pan, Qunxiong, Jiangman Zhao, Mingzhu Li, et al.. (2019). Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing. Carcinogenesis. 41(1). 18–24. 34 indexed citations

Li, Huiqiang, Jiangman Zhao, Jianhua Zhang, et al.. (2019). Detection of ctDNA in the plasma of patients with papillary thyroid carcinoma. Experimental and Therapeutic Medicine. 18(5). 3389–3396. 8 indexed citations

Zhao, Jiangman, Jian Zhang, Xiaoyu Liu, et al.. (2018). Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report. Experimental and Therapeutic Medicine. 16(3). 2527–2533. 4 indexed citations

10.

Pan, Qunxiong, et al.. (2017). Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma. Molecular and Clinical Oncology. 6(4). 566–574. 23 indexed citations

11.

Wang, Xuejin, et al.. (2015). The novel mTOR inhibitor Torin-2 induces autophagy and downregulates the expression of UHRF1 to suppress hepatocarcinoma cell growth. Oncology Reports. 34(4). 1708–1716. 46 indexed citations

12.

Wang, Xuejin, et al.. (2015). miR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1. Oncotarget. 6(34). 36231–36244. 59 indexed citations

13.

Pan, Qunxiong, et al.. (2015). A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer. OncoTargets and Therapy. 8. 1375–1375. 72 indexed citations

14.

Chen, Wanhua, Qunxiong Pan, Ya‐Yun Chen, et al.. (2014). ERCC1 Single Nucleotide Polymorphism C8092A, but Not Its Expression Is Associated with Survival of Esophageal Squamous Cell Carcinoma Patients from Fujian Province, China. PLoS ONE. 9(9). e106600–e106600. 15 indexed citations

15.

Pan, Qunxiong, et al.. (2014). The Glasgow Prognostic Score Is an Independent Prognostic Predictor of Hepatocellular Carcinoma Following Radical Resection. Oncology Research and Treatment. 37(4). 192–197. 11 indexed citations

16.

Xu, Yunhua, Qunxiong Pan, Chongren Wang, et al.. (2014). Genetic polymorphisms in oxidative stress-related genes are associated with clinical outcome in patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitors.. PubMed. 4(6). 934–42. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact